Semantic Scholar uses AI to extract papers important to this topic.
We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing… Expand SummaryAbstractBoostrix® is a three-pertussis component, combined, reduced-antigen content tetanus, diphtheria, and acellular… Expand BACKGROUND
Older adults, especially those over 65 years, are at risk of more severe morbidity from diphtheria, tetanus and… Expand On July 8, 2011, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced… Expand OBJECTIVE
In order to search the preparation process and optimazing dosage ratio of adsorbed diphtheria-tetanus-acellular… Expand Pertussis continues to circulate in Chinese communities and older children, adolescents and adults are sources of infection for… Expand Pertussis remains a serious problem in many countries. Even in countries with high vaccine coverage and a long vaccination… Expand On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced… Expand GlaxoSmithKline plc has developed and launched Boostrix, a subunit vaccine for use in adolescents and adults as a booster… Expand